An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge, Tingzhong Tian, Suling Huang, Fangping Wan, Jingxin Li, Shuya Li, Xiaoting Wang, Hui Yang, Lixiang Hong, Nian Wu, Enming Yuan, Yunan Luo, Lili Cheng, Chengliang Hu, Yipin Lei, Hantao Shu, Xiaolong Feng, Ziyuan Jiang, Yunfu Wu, Ying Chi, Xiling Guo, Lunbiao Cui, Liang Xiao, Zeng Li, Chunhao Yang, Zehong Miao, Ligong Chen, Haitao Li, Hainian Zeng, Dan Zhao, Fengcai Zhu, Xiaokun Shen, Jianyang Zeng

Open source

DOI: 10.1038/s41392-021-00568-6
Published: 2021-04-24
Container: Signal Transduction and Targeted Therapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41392-021-00568-6,
  title = {An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19},
  author = {Yiyue Ge and Tingzhong Tian and Suling Huang and Fangping Wan and Jingxin Li and Shuya Li and Xiaoting Wang and Hui Yang and Lixiang Hong and Nian Wu and Enming Yuan and Yunan Luo and Lili Cheng and Chengliang Hu and Yipin Lei and Hantao Shu and Xiaolong Feng and Ziyuan Jiang and Yunfu Wu and Ying Chi and Xiling Guo and Lunbiao Cui and Liang Xiao and Zeng Li and Chunhao Yang and Zehong Miao and Ligong Chen and Haitao Li and Hainian Zeng and Dan Zhao and Fengcai Zhu and Xiaokun Shen and Jianyang Zeng},
  year = {2021},
  journal = {Signal Transduction and Targeted Therapy},
  doi = {10.1038/s41392-021-00568-6},
  url = {https://doi.org/10.1038/s41392-021-00568-6}
}

RIS

TY  - JOUR
TI  - An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
AU  - Yiyue Ge
AU  - Tingzhong Tian
AU  - Suling Huang
AU  - Fangping Wan
AU  - Jingxin Li
AU  - Shuya Li
AU  - Xiaoting Wang
AU  - Hui Yang
AU  - Lixiang Hong
AU  - Nian Wu
AU  - Enming Yuan
AU  - Yunan Luo
AU  - Lili Cheng
AU  - Chengliang Hu
AU  - Yipin Lei
AU  - Hantao Shu
AU  - Xiaolong Feng
AU  - Ziyuan Jiang
AU  - Yunfu Wu
AU  - Ying Chi
AU  - Xiling Guo
AU  - Lunbiao Cui
AU  - Liang Xiao
AU  - Zeng Li
AU  - Chunhao Yang
AU  - Zehong Miao
AU  - Ligong Chen
AU  - Haitao Li
AU  - Hainian Zeng
AU  - Dan Zhao
AU  - Fengcai Zhu
AU  - Xiaokun Shen
AU  - Jianyang Zeng
PY  - 2021
JO  - Signal Transduction and Targeted Therapy
DO  - 10.1038/s41392-021-00568-6
UR  - https://doi.org/10.1038/s41392-021-00568-6
ER  -

APA

Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Wang, X., Yang, H., Hong, L., Wu, N., Yuan, E., Luo, Y., Cheng, L., Hu, C., Lei, Y., Shu, H., Feng, X., Jiang, Z., Wu, Y., Chi, Y., Guo, X., Cui, L., Xiao, L., Li, Z., Yang, C., Miao, Z., Chen, L., Li, H., Zeng, H., Zhao, D., Zhu, F., Shen, X., & Zeng, J. (2021). An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-021-00568-6

Source records

crossref · retrieved 2026-09-26T15:51:40.632Z